GXP

De-risking Your Supply Chain: Considerations from a Supply Chain Maps Management Program

In a detailed analysis of the crisis, Pew Health Group published a white paper entitled After Heparin: Protecting Consumers from the Risks of Substandard and Counterfeit Drugs.  The white paper provides several insights into the complexities of modern pharmaceutical supply chains and the potential risks which now threaten the product lifecycle, from supply and manufacturing through to distribution of the finished drug.  The white paper highlights some of the key contributing factors as: Globalization, increased outsourcing of manufacturing, the complexity of pharmaceutical distribution...

This content is only available to IVT members.
Get help maintaining your knowledge . Read More!

If you are already a member and you do not have access to this article, upgrade your membership.
Need help? Read our FAQs.




Product Added Successfully

This product has been added to your account and you can access it from your dashboard. As a member, you are entitled to a total of 0 products.

Do you want access to more of our products? Upgrade your membership now!

Your Product count is over the limit

Do you want access to more of our products? Upgrade your membership now!

Product added to cart successfully.

You can continue shopping or proceed to checkout.